{"entity":{"id":"nct07402070","kind":"trial","name":"IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer","aka":[],"tldr":"A phase 2 trial of IBI363 in lung cancer, run by Innovent Biologics (Suzhou) Co. Ltd., not yet recruiting.","summary":"IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer is a phase 2, interventional study registered as NCT07402070 by Innovent Biologics (Suzhou) Co. Ltd., with a registry enrolment figure of 10 participants, started 2026-02-04 and due to reach its primary completion in 2026-12-31. Interventions recorded: IBI363. Conditions listed: Resectable Stage II-III Non-small Cell Lung Cancer. Primary outcome: Pathologic Complete Response (pCR) rate; Safety parameters: the incidence of Treatment-related Adverse Event, (TRAEs); Safety parameters: the incidence of treatment-emergent adverse events (TEAEs). Lung eligibility wording from the registry: \"Histologically or cytologically confirmed primary NSCLC:\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07402070","url":"https://clinicaltrials.gov/study/NCT07402070"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["resectable-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["ibi363"],"companies":["innovent"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07402070","phase":"2","setting":"A Phase II Study Evaluating the Efficacy and Safety of IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","enrolled":10,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07402070/","neighbours":{"cancer":[{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"drug":[{"id":"ibi363","kind":"drug","name":"IBI363","route":"/drugs/ibi363/"}],"company":[{"id":"innovent","kind":"company","name":"Innovent Biologics","route":"/companies/innovent/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}